Kudo-Saito Chie, Shirako Hiromi, Takeuchi Tadashi, Kawakami Yutaka
Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo 160-8582, Japan.
Cancer Cell. 2009 Mar 3;15(3):195-206. doi: 10.1016/j.ccr.2009.01.023.
Epithelial-mesenchymal transition (EMT) is a key step toward cancer metastasis, and Snail is a major transcription factor governing EMT. Here, we demonstrate that Snail-induced EMT accelerates cancer metastasis through not only enhanced invasion but also induction of immunosuppression. Murine and human melanoma cells with typical EMT features after snail transduction induced regulatory T cells and impaired dendritic cells in vitro and in vivo partly through TSP1 production. Although Snail(+) melanoma did not respond to immunotherapy, intratumoral injection with snail-specific siRNA or anti-TSP1 monoclonal antibody significantly inhibited tumor growth and metastasis following increase of tumor-specific tumor-infiltrating lymphocytes and systemic immune responses. These results suggest that inhibition of Snail-induced EMT could simultaneously suppress both tumor metastasis and immunosuppression in cancer patients.
上皮-间质转化(EMT)是癌症转移的关键步骤,而Snail是调控EMT的主要转录因子。在此,我们证明Snail诱导的EMT不仅通过增强侵袭能力,还通过诱导免疫抑制来加速癌症转移。转导Snail后具有典型EMT特征的小鼠和人类黑色素瘤细胞在体内外均可部分通过产生血小板反应蛋白1(TSP1)诱导调节性T细胞并损害树突状细胞。尽管Snail阳性黑色素瘤对免疫疗法无反应,但瘤内注射Snail特异性小干扰RNA(siRNA)或抗TSP1单克隆抗体可在肿瘤特异性肿瘤浸润淋巴细胞增加和全身免疫反应增强后显著抑制肿瘤生长和转移。这些结果表明,抑制Snail诱导的EMT可同时抑制癌症患者的肿瘤转移和免疫抑制。